Advertisement

Uroonkologie pp 871-882 | Cite as

Lebensqualität in der urologischen Onkologie

  • C. W. Biermann

Zusammenfassung

Das große Interesse am Thema „Lebensqualität“ muß wohl im wesentlichen darauf zurückzuführen sein, daß eine ausschließliche Berücksichtigung von Überlebenszeiten und Symptomraten zunehmend als unzureichend empfunden wird und eine grundsätzliche Diskussion über angemessene Beurteilungskriterien für medizinische Maßnahmen eingesetzt hat.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aaroson NK, Calais da Silva F, Yoshido O et al. (1986) Quality of life assessment in bladder cancer clinical trials: conceptual, methodological and practical issues. Prog Clin Biol Res 221:149–170Google Scholar
  2. Aaronson NK, Ahmedzai S, Bergmann B, Bullinger M (1993) The European Organization for Research and Treatmant of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:368–373CrossRefGoogle Scholar
  3. Bergner M, Bobbit RA, Carter WB, Gilson BS (1981) The sickness impact profile. Development and final revision of a health status measure. Med Care 19:787–805PubMedCrossRefGoogle Scholar
  4. Biermann CW, Küchler T (1996 a) Die Messung von Lebensqualität als Parameter der Ergebnisqualität im Rahmen ärztlicher Qualitätskontrolle. In: Trampisch HJ, Lange S (Hrsg) Medizinische Forschung; ärztliches Handeln. MMV Medizin Verlag, München, S 290–293Google Scholar
  5. Biermann CW, Küchler T (1996) Stellenwert der Lebensqualitätsforschung im mordernen Qualitätsmanagement im Gesundheitswesen. In: Viethen G, Maier J (Hrsg) Qualität rechnet sich. Thieme, Stuttgart, S 52–57Google Scholar
  6. Biermann CW, Herberhold D, Pannek J et al. (1994 a) Symptomatologie und Befindlichkeiten von Tumorpatienten in der Urologie — Früh- und Spätergebnisse. Tumor Diagnostik u. Therapie 15:236–239Google Scholar
  7. Biermann CW, Herberhold D, Finke W et al. (1994 b) Influence of uro-oncological surgery on quality of life. J Cancer Res Clin Oncol [Suppl 120]:94Google Scholar
  8. Biermann CW, Schmidt C, Küchler T (1995 a) Development of a quality of life questionaire in bladder cancer surgery. Br J Urology 76:412–413Google Scholar
  9. 267.
    Biermann CW, de Riese W, Herberhold D, Schulze H, Senge T, Küchler T (1995 b) Lebensqualität von Tumorpatienten in der urologischen Onkologie. In: Schwarz R, Bernhard J, Flechtner H, Küchler T (Hrsg) Lebensqualität in Onkologie II. Zuckschwerd, München Bern Wien San Francisco, S 263–Google Scholar
  10. Biermann CW, Schulze H, Küchler T (1995) Quality of life in urological cancer: Data to develop EORTC-specific tumor modules. Qual Life Res 5:399Google Scholar
  11. Biermann CW; Semjonow A, Hertle L, Küchler T (1996 b) Entwicklung eines EORTC-spezifischen Modules zur Messung von Lebensqualität nach radikaler Prostatektomie. Forum DKG [Suppl 75]Google Scholar
  12. Braslis KG, Santa-Crutz C, Brickman AL, Soloway MS (1995) Qualitya of life 12 months after radical prostatectomy. Br J Urol 75:48–53PubMedCrossRefGoogle Scholar
  13. Breslin S (1992) Quality of life: how is it measured and defined? Urol Int 46:246–251CrossRefGoogle Scholar
  14. Bullinger, M (1989) Forschungsinstrumente zur Erfassung der Lebensqualität bei Krebs — ein überblick. In: Verres R, Hasenbring M (Hrsg) Psychosoziale Aspekte der Krebsforschung. Jahrb Med Psychol, Springer, Berlin Heidelberg New York Tokyo, S 45–57Google Scholar
  15. Bussar-Maatz R, Flechter H, Weißbach L (1995) In: Schwarz R, Bernhard J, Flechtner H, Küchler T (Hrsg) Lebensqualität in Onkologie IL Zuckschwerdt, München Bern Wien San Francisco, S 115–123Google Scholar
  16. Calais da Silva F, Reis E, Costa T, Denis L, Members of Quality of Life Committee of the EORTC Genitourinary Group (1993) Quality of life in patients with prostatic cancer. Cancer 71: 1138–1142CrossRefGoogle Scholar
  17. Casslith BR, Soloway MS, Vogelzang NJ, Chou JM, Schellhammer PD, Seidmon EJ,Kennealey GT and members of the Zoladex Prostate Cancer Study Group (1992) Quality of life and psychosozial status in stage D prostate cancer. Qual Life Res 1:323–330.CrossRefGoogle Scholar
  18. Derogatis LR, Lopez M (1987) PAIS and PAIS-R: Administration, scoring and procedures. Manual of Clinical Psychometrie Research. BaltimoreGoogle Scholar
  19. Donabedian A (1966) Evaluating the quality of medical care. Milbank Mem Fund Q 44:166PubMedCrossRefGoogle Scholar
  20. Douches J, Droz JP, Desclaux B et al. (1993) Qulity of life in long-term survivors of nonseminotamatous germ cell testicular tumors. Urology 149:498–501Google Scholar
  21. Einhorn LH (1987) Treatment strategies of testicular cancer in the United States. Int J Androl 10:399–405PubMedCrossRefGoogle Scholar
  22. Fossa SD, Reitan JB, Ous S, Kaalhus O (1987) Life with an ileal conduit in cystectomized bladder cancer patients: exectations and experience. Scand J Urol Nephrol 21:97–101PubMedCrossRefGoogle Scholar
  23. Fossa SD, Aaronson N, Calais da Silva F et al. (1989) Quality of life in patients with muscle infiltrating bladder cancer and hormone resistant prostatic cancer. Eur Urol 16:335–339PubMedGoogle Scholar
  24. Fossa SD, Kaasa S, Calais da Silva F, Suciu S, Hengeveld MW (1992) Quality of life in prostate cancer patients. Prostate [Suppl. 4]: 145–148PubMedCrossRefGoogle Scholar
  25. Fossa SD, Moynihan C, Serbouti S (1996) Patients’ and doctors’ perception of long-term morbidity in patients with testicular cancer clinical stage I. Support Care Cancer 4:118–128PubMedCrossRefGoogle Scholar
  26. Fowler FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wenneberg J (1995) Effect of radical prostatectomy for prostate cancer on patient quality of life: results form a medicare surgery. Urology 45:1007–1015PubMedCrossRefGoogle Scholar
  27. Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4:1772–1779PubMedGoogle Scholar
  28. Gough IR, Furnival CM, Schilder L et al. (1983) Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 19:1161–1165PubMedCrossRefGoogle Scholar
  29. Helgason AR, Fredrikson M, Adolfsson J, Steineck G (1995) Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol Phys 32:33–39PubMedCrossRefGoogle Scholar
  30. Herr HW (1987) Strategies for the management of recurrent and advanced urological cancers. Quality of life. Cancer [Suppl 60]: 623–630Google Scholar
  31. Hunt S, McKenna SP, Mc Ewen J, Wiliams J, Papp E (1981) The Nottingham Health Profile: Subjective health status and medical consultations. Soc Sci Med 15:221–229Google Scholar
  32. Karnofsky DA, Adelmann WH, Craver FI et al. (1948) The use of nitrogen mustard in the palliative treatment of carcinoma. Cancer 1:634–656CrossRefGoogle Scholar
  33. Klussmann R, Arnold G, Schewe S (1989) Leben nach einer Urostomieoperation. Eine retrospektive Untersuchung. Urologe 28:209–212Google Scholar
  34. Küchler T (1992) Lebensqualität post operationem. HabiliatationsschriftGoogle Scholar
  35. Küchler T (1995) Entwicklung der Lebensqualitätsmessung in der EORTC — der EORTC QLQ C-30. In: Schwarz R, Bernhard J, Flechtner H, Küchler T (Hrsg) Lebensqualität in Onkologie IL Zuckschwerdt, München Bern Wien San Francisco, S 71–76Google Scholar
  36. Küchler T, Schreiber HW (1989) Lebensqualität in der Allgemeinchirurgie — Konzept und praktische Möglichkeiten der Messung. HäB 43:246–259Google Scholar
  37. Lim AJ, Brandon AH, Fiedler J et al. (1995) Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urology 154:1420–1425CrossRefGoogle Scholar
  38. Litwin MS (1995) Measuring health related quality of life in men with prostate cancer. J Urology 152:1882–1887Google Scholar
  39. Litwin, MS, Hays RD, Fink A et al. (1995) Quality of life outcomes in men treated for localized prostate cancer. JAMA 273:129–135PubMedCrossRefGoogle Scholar
  40. Lynch WJ, Jenkins BJ, Fowler CG, Hope-Stone HF, Blandy JP (1992) The quality of life after radical radiotherapy for bladder cancer. Br J Urol 70:519–521PubMedGoogle Scholar
  41. Mansson A, Johnson G, Mansson W (1987) Quality of life after cystectomy. Comparison between patients with conduit and those with continent caecal reservoir urinary diversion. Br J Urol [Suppl 62]: 623–630Google Scholar
  42. Miller AB, Hoogstraaten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214PubMedCrossRefGoogle Scholar
  43. Mommsen S, Jakobsen A, Sell A (1989) Quality of life in patients with advanced bladder cancer. A randomized study comparing cystectomy and irradiation- the Danish Bladder Cancer Study Group (DAVECA protocol 8201). Scand J Urol Nephrol [Suppl 1251:115–120Google Scholar
  44. Muthny FA (1995) Möglichkeiten und Grenzen der Meßbarkeit der Lebensqualität (LQ) — Fragestellungen, Operationalisierungen und Anwendungsbeispiele. In: Schwarz R, Bernhard J, Flechtner H, Küchler T (Hrsg) Lebensqualität in Onkologie IL Zuckschwerdt, München Bern Wien San Francisco, S 51–70Google Scholar
  45. Priestmann TJ, Baum M (1976) Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1:899–901CrossRefGoogle Scholar
  46. Schipper H, Clinch J, Mc Murray A, Levitt M (1984) Measuring the quality of cancer patients: The functional living index cancer: Development and validation. J Clin Oncol 2:472–483PubMedGoogle Scholar
  47. Schwarz R, Flechtner H, Küchler T, Bernhard J, Hürny C (1991) Konsensus-Konferenz: Erfassung von Lebensqualität in der Onkologie — Konzepte, Methodik und Anwendung. Mitt Dtsch Ges Chir 20:20Google Scholar
  48. Schwarz R, Flechtner H, Küchler T, Bernhard J, Hürny C (1995) Leitlinien für eine inhaltlich adäquate und methodengerechte Erfassung von Lebensqualität in der Onkologie: Ein Positionspapier. Form DKG 10:68–72Google Scholar
  49. Sommerhoff CH (1982) Altersverteilung. In: Weißbach L, Hildenbrand G (Hrsg) Register und Verbundstudie für Hodentumoren, Bonn. Ergebnisse einer prospektiven Untersuchung. Zuckschwerdt, München Berlin, S 209–214Google Scholar
  50. Spitzer WO, Bobson AJ, Hall J et al. (1981) Measuring the quality of cancer patients. A concise QL-Index for use by physcians. J Chron Dis 34:585–597PubMedCrossRefGoogle Scholar
  51. Sprangers MAG, Cull A, Bjordal K, Grönvold M, Aaronson NK for the EORTC Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 2:287–295PubMedCrossRefGoogle Scholar
  52. Weinstein MC (1983) Cost-effective priorities for cancer prevention. Science 221:17–23PubMedCrossRefGoogle Scholar
  53. Zubrod CG, Schneidermann, M, Frei E et al. (1969) Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thio-phosphoramide. J Chron Dis 11:7–33CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • C. W. Biermann

There are no affiliations available

Personalised recommendations